证券代码：300607 证券简称：拓斯达 债券代码：123101 债券简称：拓斯转债 广东拓斯达科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |------------|---------------------------|------------|---------| | | | | 2023004 | | | □特定对象调研 □分析师会议 | | | | | □媒体采访 | 业绩说明会 | | | 投资者关系 | | | | | | □新闻发布会 | 路演活动 | | | 活动类别 | | | | | | 现场参观 | | | 电话/网络会议 参与单位名称及 拓斯达 2022 年度网上业绩说明会采用网络远程方式进行，面 向全体投资者 人员姓名 时间 2023 年 5 月 11 日 15:00-17:00 地点 深圳证券交易所"互动易平台"http://irm.cninfo.com.cn "云访谈"栏目 | --- | |----------------------------| | 董事长、总裁：吴丰礼 | | 独立董事：冯杰荣 | | 财务总监：周永冲 | ...

证券代码：300607 证券简称：拓斯达 公告编号：2023-040 债券代码：123101 债券简称：拓斯转债 广东拓斯达科技股份有限公司 关于举行2022年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 广东拓斯达科技股份有限公司（以下简称"公司"）已于 2023 年 4 月 25 日在巨潮资讯网上披露了《2022 年年度报告》及《2022 年 年度报告摘要》。为使广大投资者进一步了解公司 2022 年度经营情 况，公司将举行 2022 年度网上业绩说明会，具体安排如下： 一、会议召开信息及参与方式 公司定于 2023 年 5 月 11 日（星期四）下午 15:00—17:00 举行 2022 年度网上业绩说明会，本次年度业绩说明会将通过深圳证券交 易所提供的"互动易"平台举行，投资者可登录"互动易"网站 （http://irm.cninfo.com.cn），进入"云访谈"栏目参与本次年度 业绩说明会。 为充分了解投资者关注的方向、提高交流的效率，现就本次说明 会提前向投资者公开征集问题，广泛听取投资者的意见和建议。投资 者可提前登 ...

Financial Performance - The company's revenue for Q1 2023 was ¥799,058,889.37, a decrease of 13.98% compared to ¥928,893,987.73 in the same period last year[5] - Net profit attributable to shareholders was ¥12,050,075.30, down 77.62% from ¥53,837,484.98 year-on-year[5] - Basic and diluted earnings per share were both ¥0.03, representing a decrease of 76.92% from ¥0.13 in the same period last year[5] - Total operating revenue for Q1 2023 was CNY 799,058,889.37, a decrease of 14.0% compared to CNY 928,893,987.73 in Q1 2022[16] - Net profit for Q1 2023 was CNY 11,531,729.06, a decline of 78.8% compared to CNY 54,417,805.92 in Q1 2022[18] Cash Flow - The net cash flow from operating activities was -¥172,925,896.48, a decline of 458.11% compared to ¥48,288,128.58 in the previous year[5] - Total cash inflow from operating activities was 692,236,054.12 CNY, down from 971,508,444.99 CNY, reflecting a decrease of approximately 28.7% year-over-year[20] - Cash outflow from operating activities totaled 865,161,950.60 CNY, compared to 923,220,316.41 CNY in the previous period, showing a reduction of about 6.3%[20] - The net cash flow from investing activities was -30,580,859.02 CNY, a decline from 33,282,126.92 CNY in the previous period, indicating increased investment expenditures[20] - The net cash flow from financing activities was 93,510,385.34 CNY, a recovery from -187,455,792.43 CNY in the previous period, indicating improved financing conditions[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,737,507,405.23, an increase of 1.29% from ¥6,651,728,229.71 at the end of the previous year[5] - Total liabilities rose to CNY 4,322,683,364.72, compared to CNY 4,243,334,281.13 in the previous year[15] - The company's cash and cash equivalents at the end of the period amount to ¥979,080,296.27, down from ¥1,056,698,243.36 at the beginning of the year[13] Shareholder Information - Total number of common shareholders at the end of the reporting period is 33,057[10] - The largest shareholder, Wu Xingli, holds 34.00% of shares, totaling 144,629,860 shares, with 17,680,000 shares pledged[10] - The company has a total of 139,971,897 restricted shares, with no shares released during the reporting period[11] Research and Development - The company has ongoing research and development efforts, although specific new products or technologies were not detailed in the report[12] - Research and development expenses for Q1 2023 were CNY 23,312,449.09, an increase of 8.0% from CNY 21,586,847.29 in Q1 2022[16] Other Financial Metrics - The weighted average return on equity was 0.51%, down from 2.41% in the same period last year, a decrease of 1.90%[5] - The company reported a significant increase in receivables, with notes receivable rising by 59.67% to ¥240,129,635.50[8] - Long-term borrowings increased by 34.46% to ¥218,119,240.51, primarily due to additional loans from financial institutions[8] - The company reported a decrease in asset impairment losses by 67.97%, amounting to -¥7,913,236.77, due to reduced inventory write-downs[8] - Deferred income tax assets increased to CNY 89,852,565.99 from CNY 82,205,215.82 year-over-year[14] Audit Status - The company’s first-quarter report was not audited, which may affect the reliability of the financial data presented[22]

Financial Performance - In 2022, the company achieved operating revenue of 4.984 billion yuan, a year-on-year increase of 51%, and a net profit attributable to shareholders of 160 million yuan, up 144% year-on-year[4]. - The total revenue for the company in 2022 was approximately 4.98 billion yuan, with a gross profit margin of 18.55%, reflecting a decrease of 5.99% compared to the previous year[166]. - The net profit attributable to shareholders increased by 144.16% compared to the previous year[133]. - The company reported a revenue of 1.2 billion RMB for the fiscal year 2022, representing a year-over-year growth of 15%[40]. - The company’s overall gross margin for the reporting period was 18.55%, a decrease of 5.99 percentage points from the previous year[134]. - The net cash flow from operating activities improved to ¥139,277,353.81 in 2022, compared to a negative cash flow of ¥328,811,706.83 in 2021, marking a 142.36% increase[46]. - The company reported a quarterly revenue of ¥1,694,987,423.95 in Q4 2022, the highest among the four quarters[48]. - The company’s gross profit from self-manufactured products was 239.70 million yuan, with a gross margin of 51.04%, despite a 33.98% decline in sales revenue[163]. Product Development and Innovation - The company launched multiple new products, including three new SCARA robots and three six-axis robots, as well as two new CNC machine tools, enhancing applications in various sectors such as 3C, new energy, automotive, and medical[4]. - The company made significant progress in core technologies, with 672 authorized patents, including 88 invention patents, and 75 software copyrights as of December 31, 2022[5]. - The company plans to increase R&D investment in industrial robots, injection molding machines, and CNC machine tools to boost market competitiveness and overall market share[18]. - The company has focused on product optimization and technological upgrades to enhance market competitiveness and customer satisfaction[137]. - The TMCR series robot controller platform has been mass-produced and applied in various industrial robots, enhancing usability and digital capabilities[142]. - The company has initiated the research and production of all-electric injection molding machines, with trial operations conducted at customer sites in 2022[79]. - The company’s focus on R&D and product upgrades aims to meet the evolving demands of the market and enhance operational efficiency[110]. Market Expansion and Strategy - The company intends to expand its overseas market presence, aligning with the needs of downstream customers who are establishing factories abroad[15]. - The company is actively pursuing market expansion in Southeast Asia, with plans to establish a new manufacturing facility in Vietnam by Q3 2023[40]. - The company plans to continue cost reduction and efficiency improvement initiatives, including the establishment of a dedicated cost reduction team for project management[14]. - The company aims to enhance its brand influence by creating benchmark customers and cases through continuous innovation in core components and product technology[21]. - The company plans to continue expanding its market presence through various promotional strategies, including industry exhibitions and online marketing[132]. Operational Efficiency and Cost Management - The company focused on operational efficiency, with a reduction of over 6 percentage points in the proportion of period expenses compared to 2021, emphasizing sustainable profit and cash flow[7]. - The company emphasizes its mission to make industrial manufacturing better and aims to drive down costs and improve efficiency in the industry[22]. - The company has implemented an Integrated Product Development (IPD) framework to streamline product development processes and improve delivery efficiency[38]. - The company has established a comprehensive sales network with nearly 30 offices and over 200 sales personnel, serving more than 15,000 customers[146]. Industry Trends and Market Insights - In 2021, the global industrial robot installation reached 383,500 units, a year-on-year increase of 31%, marking a historical high[57]. - In 2022, China's industrial robot sales exceeded 280,000 units, with domestic brands capturing over 35% market share in the domestic industrial robot body market[58]. - The "machine replaces human" demand is expected to drive significant growth in the industrial robot sector due to rising labor costs and a decreasing labor force[62]. - The Chinese government has implemented various policies to support the development of industrial robots, aiming for a 20% annual growth in industry revenue during the 14th Five-Year Plan period[61]. - The competitive landscape is shifting as domestic companies enhance their value through motion control technology and differentiation strategies, paving the way for broader market opportunities[65]. Challenges and Risks - The company faces risks such as macroeconomic fluctuations, raw material shortages, accounts receivable risks, and talent shortages, which investors should be aware of[25]. - The company acknowledges the challenges of expanding its product line while maintaining competitive advantages in a rapidly evolving market[22]. Financial Management and Investments - The company raised approximately 600 million RMB through a public offering in 2019 for automation projects, with 280 million RMB redirected to the injection molding project in 2022[148]. - The company successfully raised 61.177 million RMB through convertible bonds in 2021, with project implementation extended to May 31, 2024, due to external factors[150]. - The total amount of funds raised through public offering and convertible bonds is RMB 126,433.38 million, with RMB 20,082.33 million already utilized[195]. - The company has committed RMB 18,516.32 million for working capital, with a utilization rate of 99.97%[200].

证券代码：300607 证券简称：拓斯达 1 广东拓斯达科技股份有限公司 投资者关系活动记录表 编号：2017006 | --- | --- | --- | |-----------------------------|------------------------------|--------------------------------------------------------| | | | | | | ■ | 特定对象调研 □分析师会议 | | | □ 媒体采访 □业绩说明会 | | | 投资者关系 | □ 新闻发布会 □路演活动 | | | 活动类别 | ■ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | | 兴业证券、东吴证券、中泰证券、广证恒生、长城证 | | 人员姓名 | | 券、摩根士丹利华鑫基金、磐厚资本、 | | | | | | 时间 | 2017 年 5 月 11 日 | | | 地点 | 公司 | | | 上市公司 接待人员姓名 | 周永冲。 | 董事长、总经理：吴丰礼；董事会秘书：丘乐乐；财务总监： | | | | | | 投 ...

证券代码：300607 证券简称：拓斯达 广东拓斯达科技股份有限公司 投资者关系活动记录表 编号：2017005 | --- | --- | --- | |-----------------------------|-----------------------------|--------------------------------------------------------| | | | | | | ■ | 特定对象调研 □分析师会议 | | | □ 媒体采访 □业绩说明会 | | | 投资者关系 | □ 新闻发布会 □路演活动 | | | 活动类别 | ■ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | | 天风证券、景顺长城基金、长城基金、鹏华基金、博时 | | 人员姓名 | 基金、招商基金、融通基金 | | | 时间 | 2017 年 5 月 2 日 | | | 地点 | 公司 | | | 上市公司 | | 董事长、总经理：吴丰礼；董事会秘书：丘乐乐；财务总监： | | 接待人员姓名 | 周永冲。 | | | 投资者关系活动 主要内容介绍 | ...

证券代码：300607 证券简称：拓斯达 1 广东拓斯达科技股份有限公司 投资者关系活动记录表 编号：2017003 | --- | --- | --- | |-----------------------------|-----------------------------|----------------------------------------------| | | | | | | ■ | 特定对象调研 □分析师会议 | | | □ | 媒体采访 □业绩说明会 | | 投资者关系 | □ 新闻发布会 □路演活动 | | | 活动类别 | ■ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 人员姓名 | 天风证券、广发证券 | | | 时间 | 2017 年 3 月 6 日 | | | | | | | 地点 | 公司会议室 | | | 上市公司 接待人员姓名 | 董事会秘书：丘乐乐 | | | 投资者关系活动 主要内容介绍 | 一、公司现场参观。 | | | | | 二、情况介绍及问答环节 | | | 1 、情况介绍： | 拓斯达从 2007 年 50 ...